| 82 | 7 | 7 |
| 下载次数 | 被引频次 | 阅读次数 |
目的观察龙琥醒脑颗粒联合西医治疗对脑出血后脑水肿患者脑脊液白介素-1β(IL-1β)、S-100蛋白(S-100)水平的影响。方法选取安徽省六安市人民医院神经内科2016年1月-2018年7月收治的110例脑出血患者,按随机数表法分为中西医结合组与西医组,每组55例。所有患者入院后立即给予常规治疗,其中西医组静脉注射托拉塞米注射液,20 mg/次,12 h/次。连续治疗2周。中西医结合组在西医组治疗基础上联合龙琥醒脑颗粒,l包/次,2次/d,连续服用2周。比较2组总有效率以及治疗前与治疗2周后患者的脑水肿体积、血肿体积、脑脊液IL-1β、S-100水平及治疗期间不良反应总发生率。结果中西医结合组整体疗效优于西医组,差异有统计学意义(P<0.05)。中西医结合组治疗总有效率为94.55%(52/55),显著高于西医组81.82%(45/55)(P<0.05)。2组患者治疗前脑水肿体积、血肿体积的差异无统计学意义(P>0.05);治疗2周后,2组患者的脑水肿体积、血肿体积均较治疗前减小,差异有统计学意义(P<0.05)。中西医结合组治疗2周后患者的脑水肿体积、血肿体积分别为(12.45±2.95) mL与(21.01±4.77) mL,低于西医组[(14.40±2.86) mL与(24.02±4.85) mL],差异有统计学意义(P<0.05)。2组治疗前脑脊液IL-1β、S-100水平差异无统计学意义(P>0.05);治疗2周后,2组脑脊液IL-1β、S-100均较治疗前降低,差异有统计学意义(P<0.05)。中西医结合组治疗2周后患者脑脊液IL-1β、S-100水平分别为(2.11±0.10) pg/mL与(1.04±0.10) pg/mL,低于西医组[(2.18±0.11) pg/mL与(1.18±0.12) pg/mL],差异有统计学意义(P<0.05)。中西医结合组不良反应总发生率为10.91%(6/55),西医组为7.27%(4/55),差异无统计学意义(P>0.05)。结论龙琥醒脑颗粒联合西医治疗脑出血后脑水肿可有效促进血肿及脑水肿的消退,减轻脑水肿对脑组织的损害,促使脑脊液中IL-1β、S-100水平降低,且安全、可靠,值得推广。
Abstract:Objective To observe the effect of Longhu Xingnao Granule combined with western medicine on the levels of interleukin-1 beta(IL-1β) and S-100 protein in cerebrospinal fluid(CSF) of patients with cerebral edema after cerebral hemorrhage. Methods A total of 110 patients with cerebral hemorrhage admitted to the Department of Neurology, Liuan People′s Hospital in Anhui Province from January 2016 to July 2018 were randomly divided into the integrated group of traditional Chinese and western medicine and the western medicine group with 55 cases in each group. All patients were given routine treatment immediately after admission, of which the western medicine group was given intravenous torasemide injection, 20 mg/time, 12 h/time, lasting for 2 weeks. On the basis of the treatment of western medicine group, combined with Longshu Xingnao Granule, the integrated group took Longshu Xingnao Granule twice a day for another 2 weeks. The total effective rate, the volume of brain edema, the volume of hematoma, the levels of IL-1β and S-100 in CSF and the total incidence of adverse reactions during treatment were compared between the two groups. Results The overall curative effect of the integrated traditional Chinese and western medicine group was better than that of the western medicine group, and the difference was statistically significant(P<0.05). The total effective rate of the integrated traditional Chinese and western medicine group was 94.55%(52/55), which was significantly higher than that of the western medicine group [81.82%(45/55), P<0.05]. There was no significant difference in the volume of brain edema and hematoma between the two groups before treatment(P>0.05); after 2 weeks of treatment, the volume of brain edema and hematoma in the two groups decreased compared with before treatment, and the difference was statistically significant(P<0.05). Two weeks after treatment, the volume of brain edema and hematoma in the integrated group were(12.45±2.95) mL and(21.01±4.77) mL respectively, which were lower than those in the western group [(14.40±2.86) mL and(24.02±4.85) mL], with significant difference(P<0.05). There was no significant difference in the levels of IL-1β and S-100 in CSF between the two groups before treatment(P>0.05); after 2 weeks of treatment, the levels of IL-1β and S-100 in CSF of the two groups were significantly lower than those before treatment(P<0.05). After 2 weeks of treatment, the levels of IL-1β and S-100 in CSF of patients in the integrated traditional Chinese and western medicine group were(2.11±0.10) pg/mL and(1.04±0.10) pg/mL respectively, which were lower than those in the western medicine group [(2.18±0.11) pg/mL and(1.18±0.12) pg/mL], with significant difference(P<0.05). The total incidence of adverse reactions was 10.91%(6/55) in the integrated Chinese and western medicine group and 7.27%(4/55) in the western medicine group, with no significant difference(P>0.05). Conclusion The Longhu Xingnao Granule combined with western medicine treatment of cerebral edema after cerebral hemorrhage can effectively promote the regression of hematoma and cerebral edema, reduce brain edema damage to brain tissue, promote the reduction of IL-1β and S-100 levels in CSF, and it is safe and reliable, which is worthy of promotion.
[1] 孙志刚,曹艳丽.脑出血急性期合并高血压患者血压与血肿、水肿的相关性研究[J].中国实用神经疾病杂志,2016,19(8):29-30.
[2] 武柠子,马慧萍,王宁,等.脑水肿分子机制的研究进展[J].解放军医药杂志,2016,28(6):14-18.
[3] 任万印.脑水肿发病机制及治疗的研究进展[J].医学综述,2012,18(6):822-824.
[4] 徐可,杨建军.颅脑损伤后脑水肿的发病机制及研究进展[J].中华脑科疾病与康复杂志(电子版),2015,5(3):184-187.
[5] 余文运,喻坚柏,罗刚,等.龙琥醒脑颗粒对脑出血模型小鼠cAMP/PKA/AQP4信号通路的调控作用[J].广西医科大学学报,2018,35(2):162-165.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南(2014)[J].中华神经科杂志,2015,48(6):435-444.
[7] 赵晓君,吴晓光,王建福,等.脑出血继发脑水肿的病理机制研究[J].中风与神经疾病杂志,2016,33(11):1054-1056.
[8] 张新龙,李文华,任军,等.高原脑水肿发病机制及药物作用分子机制研究进展[J].中国全科医学,2017,20(5):622-627.
[9] 王胜利,富奇志.脑出血后水肿体积相关危险因素分析[J].中国实用神经疾病杂志,2018,21(6):596-601.
[10] 王红娟.中西医结合治疗脑出血后脑水肿的疗效观察[J].中西医结合心血管病电子杂志,2015,3(16):57-58.
[11] 王金成,幺新英,李晓,等.从“血不利则为水”谈脑水肿的治疗[J].世界中西医结合杂志,2015,10(3):306-307.
[12] 朱景哲,任洪亮.脑水肿的中医理论探析[J].中国民间疗法,2017,25(6):4-4.
[13] 宋晓洁,冯伟平,韩雪娇,等.IL-1β及BDNF水平变化与高血压脑出血患者脑水肿的关系[J].现代生物医学进展,2016,16(31):6144-6147.
[14] 胡朝晖,郑永汉,张伟超,等.血清S100β蛋白及IL-10含量预测急性脑出血患者迟发性脑水肿的临床意义探析[J].黑龙江医药,2017,30(2):267-269.
[15] 董万青,赵秀云,马立华,等.脑出血患者血清S-100β蛋白、超敏C反应蛋白动态变化及其与认知功能的相关性[J].实用临床医药杂志,2016,20(5):22-24.
[16] 俞梦瑾,刘锦,孙冬玮,等.黄芪治疗重型颅脑损伤后脑水肿及颅内高压的疗效观察[J].中西医结合心脑血管病杂志,2016,14(12):1331-1334.
[17] 余文运,喻坚柏,罗刚.龙琥醒脑颗粒治疗急性脑出血后脑水肿形成的临床研究[J].中医药导报,2018,24(6):63-65.
基本信息:
中图分类号:R743.34
引用信息:
[1]陈生,陈然,吴章松,等.龙琥醒脑颗粒联合西医治疗对脑出血后脑水肿患者脑脊液IL-1β、S-100蛋白水平的影响[J].新疆医科大学学报,2019,42(09):1193-1197.
基金信息:
安徽省六安市人民医院科研项目(2015xkj142)
2019-08-16
2019-08-16